F. Ango, G. Di-cristo, H. Higashiyama, V. Bennett, P. Wu et al., Ankyrin-based subcellular gradient of neurofascin, an immunoglobulin family protein, directs GABAergic innervation at purkinje axon initial segment, Cell, vol.119, pp.257-272, 2004.

M. L. Bondy, M. E. Scheurer, B. Malmer, J. S. Barnholtz-sloan, F. G. Davis et al., Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium, Cancer, vol.113, pp.1953-1968, 2008.

A. Bonni, Y. Sun, M. Nadal-vicens, A. Bhatt, D. A. Frank et al., Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway, Science, vol.278, pp.477-483, 1997.

D. Brodbeck, P. Cron, and B. A. Hemmings, A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain, J Biol Chem, vol.274, pp.9133-9136, 1999.

D. J. Brat, R. G. Verhaak, K. D. Aldape, W. K. Yung, S. R. Salama et al., Cancer Genome Atlas Research Network et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas, N Engl J Med, vol.372, pp.2481-2498

M. Ceccarelli, F. P. Barthel, T. M. Malta, T. S. Sabedot, S. R. Salama et al., Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma, Cell, vol.164, pp.550-563, 2016.

V. Codd, C. P. Nelson, A. E. Mangino, M. Deelen, J. Buxton et al., Identification of seven loci affecting mean telomere length and their association with disease, Nat Genet, vol.45, pp.422-427, 2013.

E. Crane, Q. Bian, R. P. Mccord, B. R. Lajoie, B. S. Wheeler et al., Condensin-driven remodelling of X chromosome topology during dosage compensation, Nature, vol.523, pp.240-244, 2015.

E. Crocetti, A. Trama, C. Stiller, A. Caldarella, R. Soffietti et al., Epidemiology of glial and non-glial brain tumours in Europe, Eur J Cancer, vol.48, pp.1532-1542, 2012.

D. Stefano, A. L. Enciso-mora, V. Marie, Y. Desestret, V. Labussiere et al., Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies, Neuro Oncol, vol.15, pp.542-547, 2013.

J. R. Dixon, I. Jung, S. Selvaraj, Y. Shen, A. Bourget et al., Chromatin architecture reorganization during stem cell differentiation, Nature, vol.518, pp.331-336, 2015.

J. E. Eckel-passow, D. H. Lachance, A. M. Molinaro, K. M. Walsh, P. A. Decker et al., Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors, N Engl J Med, vol.372, pp.2499-2508, 2015.

V. Enciso-mora, F. J. Hosking, B. Kinnersley, Y. Wang, S. Shete et al., Deciphering the 8q24.21 association for glioma, Hum Mol Genet, vol.22, pp.2293-2302, 2013.

W. A. Flavahan, Y. Drier, B. B. Liau, S. M. Gillespie, A. S. Venteicher et al., Insulator dysfunction and oncogene activation in IDH mutant gliomas, Nature, vol.529, pp.110-114, 2016.

J. Gao, B. A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, p.1, 2013.

A. Gonzalez-aguilar, A. Idbaih, B. Boisselier, N. Habbita, M. Rossetto et al., Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas, Clin Cancer Res Off J Am Assoc Cancer Res, vol.18, pp.5203-5211, 2012.

C. S. Group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

G. Gur, C. Rubin, M. Katz, I. Amit, A. Citri et al., LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation, EMBO J, vol.23, p.42, 2004.

S. Hercberg, P. Galan, P. Preziosi, S. Bertrais, L. Mennen et al., The SU. VI. MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals, Arch Intern Med, vol.164, pp.2335-2342, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01346671

J. P. Higgins, S. G. Thompson, J. J. Deeks, and D. G. Altman, Measuring inconsistency in meta-analyses, BMJ, vol.327, pp.557-560, 2003.

A. Idbaih, Y. Marie, C. Lucchesi, G. Pierron, M. E. Raynal et al., BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas, Int J Cancer J Int Cancer, vol.122, pp.1778-1786, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00310507

R. B. Jenkins, Y. Xiao, H. Sicotte, P. A. Decker, T. M. Kollmeyer et al., A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation, Nat Genet, vol.44, pp.1122-1125, 2012.

J. Jung, L. Kim, X. Wang, Q. Wu, T. Sanvoranart et al., Nicotinamide metabolism regulates glioblastoma stem cell maintenance, JCI Insight, vol.2, 2017.

A. Killedar, M. D. Stutz, A. P. Sobinoff, C. G. Tomlinson, T. M. Bryan et al., A common cancer risk-associated allele in the hTERT locus encodes a dominant negative inhibitor of telomerase, PLoS Genet, vol.11, p.86, 2015.

B. Kinnersley, M. Labussiere, A. Holroyd, D. Stefano, A. L. Broderick et al., Genome-wide association study identifies multiple susceptibility loci for glioma, Nat Commun, vol.6, p.8559, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01316579

M. Labussiere, D. Stefano, A. L. Gleize, V. Boisselier, B. Giry et al., TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations, Br J Cancer, vol.111, pp.2024-2032, 2014.

M. Labussiere, A. Idbaih, X. W. Wang, Y. Marie, B. Boisselier et al., All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2, Neurology, vol.74, pp.1886-1890, 2010.

J. H. Lee, M. Huynh, J. L. Silhavy, S. Kim, T. Dixon-salazar et al., De novo somatic mutations in components of the PI3 K-AKT3-mTOR pathway cause hemimegalencephaly, Nat Genet, vol.44, pp.941-945, 2012.

S. Li, A. P. Chou, W. Chen, R. Chen, Y. Deng et al., Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation, Neuro Oncol, vol.15, pp.57-68, 2013.

J. Z. Liu, F. Tozzi, D. M. Waterworth, S. G. Pillai, P. Muglia et al., Metaanalysis and imputation refines the association of 15q25 with smoking quantity, Nat Genet, vol.42, pp.436-440, 2010.

J. Lonsdale, J. Thomas, M. Salvatore, R. Phillips, E. Lo et al., The genotype-tissue expression (GTEx) project, Nat Genet, vol.45, pp.580-585, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01190088

D. N. Louis, A. Perry, G. Reifenberger, V. Deimling, A. Figarellabranger et al., The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, vol.131, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

J. Marchini, B. Howie, S. Myers, G. Mcvean, and P. Donnelly, A new multipoint method for genome-wide association studies by imputation of genotypes, Nat Genet, vol.39, pp.906-913, 2007.

J. S. Martin, Z. Xu, A. P. Reiner, K. L. Mohlke, P. Sullivan et al., HUGIn: Hi-C unifying genomic interrogator, Bioinformatics, 2017.

B. S. Melin, J. S. Barnholtz-sloan, M. R. Wrensch, C. Johansen, D. Il'yasova et al., Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors, Nat Genet, vol.49, pp.789-794, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01602681

V. K. Mootha, C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag et al., PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, vol.34, pp.267-273, 2003.

F. Moreira, T. R. Kiehl, K. So, N. F. Ajeawung, C. Honculada et al., NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas, Am J Pathol, vol.179, pp.462-476, 2011.

J. Okano, I. Gaslightwala, M. J. Birnbaum, A. K. Rustgi, and H. Nakagawa, Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation, J Biol Chem, vol.275, pp.30934-30942, 2000.

O. K. Park, T. S. Schaefer, and D. Nathans, In vitro activation of Stat3 by epidermal growth factor receptor kinase, Proc Natl Acad Sci, vol.93, pp.13704-13708, 1996.

N. Patterson, A. L. Price, and D. Reich, Population structure and eigenanalysis, PLoS Genet, vol.2, p.90, 2006.

C. Power and J. Elliott, Cohort profile: 1958 British birth cohort (National Child Development Study), Int J Epidemiol, vol.35, pp.34-41, 2006.

S. S. Rao, M. H. Huntley, N. C. Durand, E. K. Stamenova, I. D. Bochkov et al., A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping, Cell, vol.159, pp.1665-1680, 2014.

C. Ren, C. H. Ren, L. Li, A. A. Goltsov, and T. C. Thompson, Identification and characterization of RTVP1/GLIPR1-like genes, a novel p53 target gene cluster, Genomics, vol.88, pp.163-172, 2006.

M. Sanson, F. J. Hosking, S. Shete, D. Zelenika, S. E. Dobbins et al., Chromosome 7p11.2 (EGFR) variation influences glioma risk, Hum Mol Genet, vol.20, pp.2897-2904, 2011.

M. Sanson, Y. Marie, S. Paris, A. Idbaih, J. Laffaire et al., Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas, J Clin Oncol Off J Am Soc Clin Oncol, vol.27, pp.4150-4154, 2009.

V. Sanz-moreno, C. Gaggioli, M. Yeo, J. Albrengues, F. Wallberg et al., ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma, Cancer Cell, vol.20, pp.229-245, 2011.

G. E. Schepers, M. Bullejos, B. M. Hosking, and P. Koopman, Cloning and characterisation of the Sry-related transcription factor gene Sox8, Nucleic Acids Res, vol.28, pp.1473-1480, 2000.

A. D. Schmitt, M. Hu, J. I. Xu, Z. Qiu, Y. Tan et al., A compendium of chromatin contact maps reveals spatially active regions in the human genome, Cell Rep, vol.17, pp.2042-2059, 2016.

S. Shete, F. J. Hosking, L. B. Robertson, S. E. Dobbins, M. Sanson et al., Genome-wide association study identifies five susceptibility loci for glioma, Nat Genet, vol.41, pp.899-904, 2009.

K. Shuai, A. Ziemiecki, A. F. Wilks, A. G. Harpur, H. B. Sadowski et al., Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins, Nature, vol.366, pp.580-583, 1993.

S. N. Stacey, P. Sulem, A. Jonasdottir, G. Masson, J. Gudmundsson et al., A germline variant in the TP53 polyadenylation signal confers cancer susceptibility, Nat Genet, vol.43, pp.1098-1103, 2011.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci, vol.102, pp.15545-15550, 2005.

A. Sud, B. Kinnersley, and R. S. Houlston, Genome-wide association studies of cancer: current insights and future perspectives, Nat Rev Cancer, vol.17, pp.692-704, 2017.

K. M. Turner, Y. Sun, J. P. Granberg, K. J. Bernard, B. Hu et al., Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression, Proc Natl Acad Sci, vol.112, pp.3421-3426, 2015.

O. A. Ulanovskaya, A. M. Zuhl, and B. F. Cravatt, NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink, Nat Chem Biol, vol.9, pp.300-306, 2013.

K. M. Walsh, V. Codd, T. Rice, C. P. Nelson, I. V. Smirnov et al., Longer genotypically-estimated leukocyte telomere length is associated with increased adult glioma risk, Oncotarget, vol.6, pp.42468-42477, 2015.

K. M. Walsh, J. K. Wiencke, D. H. Lachance, J. L. Wiemels, A. M. Molinaro et al., Telomere maintenance and the etiology of adult glioma, Neuro Oncol, vol.17, pp.1445-1452, 2015.

H. Wang, T. Burnett, S. Kono, C. A. Haiman, M. Iwasaki et al., Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A, Nat Commun, vol.5, p.4613, 2014.

K. Wang, M. Li, D. Hadley, R. Liu, J. Glessner et al., PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data, Genome Res, vol.17, pp.1665-1674, 2007.

J. Wei, X. Qi, Q. Zhan, D. Zhou, Q. Yan et al., miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression, Biomed Pharmacother, vol.71, pp.112-118, 2015.

H. J. Westra, M. J. Peters, T. Esko, H. Yaghootkar, C. Schurmann et al., Systematic identification of trans eQTLs as putative drivers of known disease associations, Nat Genet, vol.45, p.1238, 2013.

H. Wickham, ggplot2: elegant graphics for data analysis, 2009.

M. Wrensch, R. B. Jenkins, J. S. Chang, R. F. Yeh, Y. Xiao et al., Variants in the CDKN2B and RTEL1 regions are associated with highgrade glioma susceptibility, Nat Genet, vol.41, pp.905-908, 2009.

H. Yan, D. W. Parsons, J. G. Mclendon, R. Rasheed, B. A. Yuan et al., IDH1 and IDH2 mutations in gliomas, N Engl J Med, vol.360, pp.765-773, 2009.

J. A. Yang, B. H. Liu, L. M. Shao, Z. T. Guo, Q. Yang et al., LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway, Int J Clin Exp Pathol, vol.8, pp.3580-3590, 2015.

C. Zhang, J. A. Doherty, S. Burgess, R. J. Hung, S. Lindstrom et al., Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study, Hum Mol Genet, vol.24, pp.5356-5366, 2015.

W. Zhang, K. Y. Hui, A. Gusev, N. Warner, S. M. Ng et al., Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-kappaB pathway gene, HEATR3, Genes Immun, vol.14, pp.310-316, 2013.

Y. Zhang, S. Ni, B. Huang, L. Wang, X. Zhang et al., Overexpression of SCLIP promotes growth and motility in glioblastoma cells, Cancer Biol Ther, vol.16, pp.97-105, 2015.

C. Zhao, Y. Deng, L. Liu, K. Yu, L. Zhang et al., Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation, Nat Commun, vol.7, 2016.

Q. L. Zhou, Z. Y. Jiang, A. S. Mabardy, D. Campo, C. M. Lambright et al., A novel pleckstrin homology domain-containing protein enhances insulin-stimulated Akt phosphorylation and GLUT4 translocation in adipocytes, J Biol Chem, vol.285, pp.27581-27589, 2010.